SNST Stock Overview
Aphex BioCleanse Systems, Inc. develops sanitizing solutions without the use of alcohol.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Sunset Capital Assets, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.006 |
| 52 Week High | US$0.04 |
| 52 Week Low | US$0.002 |
| Beta | 0 |
| 1 Month Change | -44.95% |
| 3 Month Change | -25.00% |
| 1 Year Change | n/a |
| 3 Year Change | -99.63% |
| 5 Year Change | n/a |
| Change since IPO | -99.73% |
Recent News & Updates
Recent updates
Shareholder Returns
| SNST | US Household Products | US Market | |
|---|---|---|---|
| 7D | -16.3% | 1.8% | -3.2% |
| 1Y | n/a | 2.5% | 19.3% |
Return vs Industry: Insufficient data to determine how SNST performed against the US Household Products industry.
Return vs Market: Insufficient data to determine how SNST performed against the US Market.
Price Volatility
| SNST volatility | |
|---|---|
| SNST Average Weekly Movement | n/a |
| Household Products Industry Average Movement | 2.5% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: SNST's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine SNST's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | n/a | n/a | www.aphexus.com |
Aphex BioCleanse Systems, Inc. develops sanitizing solutions without the use of alcohol. It products includes sanitizers, surface disinfectants, wound wash, and solutions for treatment of livestock. The company was incorporated in 2010 and is based in Rochester, New York.
Sunset Capital Assets, Inc. Fundamentals Summary
| SNST fundamental statistics | |
|---|---|
| Market cap | US$1.60m |
| Earnings (TTM) | US$0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs SNST overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SNST income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$0 |
| Earnings | US$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did SNST perform over the long term?
See historical performance and comparison